DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: A Danish cohort study

Martin Bjerregård Pedersen; Stephen Jacques Hamilton-Dutoit; Knud Bendix; Rhett P. Ketterling; Patrick P. Bedroske; Ivy M. Luoma; Christopher A. Sattler; Rebecca L. Boddicker; N. Nora Bennani; Peter Nørgaard; Michael Boe Møller; Torben Steiniche; Francesco D’Amore; Andrew L. Feldman

doi:10.1182/blood-2016-12-755496

DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: A Danish cohort study

Martin Bjerregård Pedersen, Stephen Jacques Hamilton-Dutoit, Knud Bendix, Rhett P. Ketterling, Patrick P. Bedroske, Ivy M. Luoma, Christopher A. Sattler, Rebecca L. Boddicker, N. Nora Bennani, Peter Nørgaard, Michael Boe Møller, Torben Steiniche, Francesco D’Amore^*, Andrew L. Feldman

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Letter › peer-review

117 Scopus citations

Original language	English (US)
Pages (from-to)	554-557
Number of pages	4
Journal	Blood
Volume	130
Issue number	4
DOIs	https://doi.org/10.1182/blood-2016-12-755496
State	Published - Jul 27 2017

Funding

The authors thank Kristina Lauridsen (Laboratory of Molecular Pathology, Aarhus University Hospital), Lindsay B. Emanuel (Department of Health Sciences Research, Mayo Clinic), and Kathryn E. Pearce (Department of Laboratory Medicine and Pathology, Mayo Clinic) for excellent technical and logistic assistance. This work was supported by grants from the Institute of Clinical Medicine, Aarhus University/Aarhus University Hospital, The Karen Elise Jensen Foundation, The A. P. Møller and Chastine Mc-Kinney Møller Foundation for General Purposes, The Eva and Henry Frænkel Foundation, The Mimi & Victor Larsens Fund, the National Institutes of Health, National Cancer Institute (R01 CA177734 and P50 CA97274), and the Department of Laboratory Medicine and Pathology, Mayo Clinic.

ASJC Scopus subject areas

Hematology
Biochemistry
Cell Biology
Immunology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/blood-2016-12-755496

Cite this

Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Ketterling, R. P., Bedroske, P. P., Luoma, I. M., Sattler, C. A., Boddicker, R. L., Bennani, N. N., Nørgaard, P., Møller, M. B., Steiniche, T., D’Amore, F., & Feldman, A. L. (2017). DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: A Danish cohort study. Blood, 130(4), 554-557. https://doi.org/10.1182/blood-2016-12-755496

@article{c7a92e31629b4427a560d1e509c8f6de,

title = "DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: A Danish cohort study",

author = "Pedersen, {Martin Bjerreg{\aa}rd} and Hamilton-Dutoit, {Stephen Jacques} and Knud Bendix and Ketterling, {Rhett P.} and Bedroske, {Patrick P.} and Luoma, {Ivy M.} and Sattler, {Christopher A.} and Boddicker, {Rebecca L.} and Bennani, {N. Nora} and Peter N{\o}rgaard and M{\o}ller, {Michael Boe} and Torben Steiniche and Francesco D{\textquoteright}Amore and Feldman, {Andrew L.}",

note = "Funding Information: The authors thank Kristina Lauridsen (Laboratory of Molecular Pathology, Aarhus University Hospital), Lindsay B. Emanuel (Department of Health Sciences Research, Mayo Clinic), and Kathryn E. Pearce (Department of Laboratory Medicine and Pathology, Mayo Clinic) for excellent technical and logistic assistance. This work was supported by grants from the Institute of Clinical Medicine, Aarhus University/Aarhus University Hospital, The Karen Elise Jensen Foundation, The A. P. M{\o}ller and Chastine Mc-Kinney M{\o}ller Foundation for General Purposes, The Eva and Henry Fr{\ae}nkel Foundation, The Mimi & Victor Larsens Fund, the National Institutes of Health, National Cancer Institute (R01 CA177734 and P50 CA97274), and the Department of Laboratory Medicine and Pathology, Mayo Clinic.",

year = "2017",

month = jul,

day = "27",

doi = "10.1182/blood-2016-12-755496",

language = "English (US)",

volume = "130",

pages = "554--557",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "4",

}

Pedersen, MB, Hamilton-Dutoit, SJ, Bendix, K, Ketterling, RP, Bedroske, PP, Luoma, IM, Sattler, CA, Boddicker, RL, Bennani, NN, Nørgaard, P, Møller, MB, Steiniche, T, D’Amore, F & Feldman, AL 2017, 'DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: A Danish cohort study', Blood, vol. 130, no. 4, pp. 554-557. https://doi.org/10.1182/blood-2016-12-755496

TY - JOUR

T1 - DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma

T2 - A Danish cohort study

AU - Pedersen, Martin Bjerregård

AU - Hamilton-Dutoit, Stephen Jacques

AU - Bendix, Knud

AU - Ketterling, Rhett P.

AU - Bedroske, Patrick P.

AU - Luoma, Ivy M.

AU - Sattler, Christopher A.

AU - Boddicker, Rebecca L.

AU - Bennani, N. Nora

AU - Nørgaard, Peter

AU - Møller, Michael Boe

AU - Steiniche, Torben

AU - D’Amore, Francesco

AU - Feldman, Andrew L.

N1 - Funding Information: The authors thank Kristina Lauridsen (Laboratory of Molecular Pathology, Aarhus University Hospital), Lindsay B. Emanuel (Department of Health Sciences Research, Mayo Clinic), and Kathryn E. Pearce (Department of Laboratory Medicine and Pathology, Mayo Clinic) for excellent technical and logistic assistance. This work was supported by grants from the Institute of Clinical Medicine, Aarhus University/Aarhus University Hospital, The Karen Elise Jensen Foundation, The A. P. Møller and Chastine Mc-Kinney Møller Foundation for General Purposes, The Eva and Henry Frænkel Foundation, The Mimi & Victor Larsens Fund, the National Institutes of Health, National Cancer Institute (R01 CA177734 and P50 CA97274), and the Department of Laboratory Medicine and Pathology, Mayo Clinic.

PY - 2017/7/27

Y1 - 2017/7/27

UR - http://www.scopus.com/inward/record.url?scp=85026293380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026293380&partnerID=8YFLogxK

U2 - 10.1182/blood-2016-12-755496

DO - 10.1182/blood-2016-12-755496

M3 - Letter

C2 - 28522440

AN - SCOPUS:85026293380

SN - 0006-4971

VL - 130

SP - 554

EP - 557

JO - Blood

JF - Blood

IS - 4

ER -

DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: A Danish cohort study

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this